Mehlisch D R, Joy E D
J Oral Surg. 1981 Jun;39(6):426-9.
In this double-blind, repeat-dose study, 323 outpatients with moderate to severe pain after oral surgery assessed zomepirac sodium, a new oral, single-entity, nonnarcotic analgesic, and APC with codeine, 30 mg, a reference standard. Pain relief obtained with 100 mg of zomepirac sodium was significantly superior to that of APC with codeine, 30 mg; 50 mg of zomepirac sodium was as effective as the reference drug. The analgesic acceptability was highest for 100 mg of zomepirac sodium. Both doses of this new drug produced significantly fewer adverse reactions than APC with codeine, 30 mg.
在这项双盲、重复给药研究中,323名口腔手术后中重度疼痛的门诊患者对一种新型口服单一实体非麻醉性镇痛药佐美酸纳和作为参考标准的含30毫克可待因的APC进行了评估。100毫克佐美酸纳所获得的疼痛缓解效果显著优于含30毫克可待因的APC;50毫克佐美酸纳的效果与参比药物相当。100毫克佐美酸纳的镇痛可接受性最高。两种剂量的这种新药产生的不良反应均明显少于含30毫克可待因的APC。